EGFR and non-small cell lung carcinoma: Other than the striking in-vitro antiproliferative profile, the hybrid scaffold was also endowed with tumour growth inhibitory potential as evidenced in human EGFR-resistance NSCLC H1975 xenograft model in vivo [331].